Is the routine use of high-resolution immunological screening of recipients of primary deceased donor kidney allografts cost-effective?
Routine use of FS in recipients of first-deceased donor kidney transplants is cost-effective.
The reduction of p21 by the alteration of the p53-DDX3 pathway plays an essential role in early-stage HPV-associated lung tumorigenesis and is correlated with poor RFS of lung cancer patients.